LifeVantage Impresses Event Attendees with Major International Announcements & New Luxury Skin Care Product
July 12 2017 - 7:30PM
LifeVantage Corporation (Nasdaq:LFVN), recently hosted an exclusive
event for thousands of distributors, business leaders and
entrepreneurs in Denver, Colorado. The 3-day Elite Academy featured
significant corporate announcements, professional development
training from more than 25 business experts and was headlined by
New York Times best-selling author, Dr. John C. Maxwell. Dr.
Maxwell has partnered with the Company to create a custom
leadership course based on his book, The 15 Invaluable Laws of
Growth to teach entrepreneurs the necessary skills to succeed in
today’s world. Dr. Maxwell's next LifeVantage seminar will
take place during the company's Elite Academy in Orlando, FL in
November 2017.
“Elite Academy is one of my favorite events and Denver exceeded
all expectations,” said LifeVantage President and Chief Executive
Officer, Darren Jensen. “In addition to delivering valuable
professional and personal development training, EA is an immensely
powerful vehicle for helping the company succeed in our mission of
biohacking the aging code and to activate the lives of millions of
people.”
The Company officially announced plans for expansion into
Germany and has planned a pre-launch date for Germany of September
1, 2017. The pre-launch will give customers a chance to purchase
products or sign-up as a distributor prior to the official launch
on January 20, 2018. “Germany is one of the top five direct selling
markets in the world,” said Senior VP of International, Courtland
Pearson. “It will be a very important and strategic market for us
with respect to the success of our global expansion efforts.”
The Company also introduced its flagship product, Protandim®
Nrf2 Synergizer to the Mexico market this week. “The successful
registration of Protandim® Nrf2 in Mexico is very exciting and we
expect a strong response now that it’s officially available,”
continued Mr. Jensen.
LifeVantage unveiled its new luxury skincare product,
TrueScience® Hand Cream. Featuring premium naturally-derived
ingredients and Nrf2 synergizers, the event quickly sold out its
available supply. Updates on TrueScience® and product
availability can be found on the Company’s website,
www.lifevantage.com/truescience.
About LifeVantage Corporation
LifeVantage Corporation is a science-based health, wellness and
anti-aging company dedicated to helping people transform themselves
internally and externally at a cellular level. Their
scientifically-validated product line includes Protandim® Nrf2 and
NRF1 Synergizers, TrueScience® Anti-Aging Skin Care Regimen,
Petandim®, AXIO® Smart Energy and the PhysIQ™ Smart Weight
Management System. LifeVantage (Nasdaq:LFVN) was founded in 2003
and is headquartered in Salt Lake City, Utah. For more information,
visit www.lifevantage.com.
Forward Looking Statements
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism,
satisfaction or disappointment with current prospects, as well as
words such as "believe," "hopes," "intends," "estimates,"
"expects," "projects," "plans," "anticipates," "look forward to"
and variations thereof, identify forward-looking statements, but
their absence does not mean that a statement is not
forward-looking. Examples of forward-looking statements include,
but are not limited to, statements we make regarding our future
growth, distributor success and shareholder value. Such
forward-looking statements are not guarantees of performance and
the Company's actual results could differ materially from those
contained in such statements. These forward-looking statements are
based on the Company's current expectations and beliefs concerning
future events affecting the Company and involve known and unknown
risks and uncertainties that may cause the Company's actual results
or outcomes to be materially different from those anticipated and
discussed herein. These risks and uncertainties include, among
others, those discussed in greater detail in the Company's Annual
Report on Form 10-K and the Company's Quarterly Report on Form 10-Q
under the caption "Risk Factors," and in other documents filed by
the Company from time to time with the Securities and Exchange
Commission. The Company cautions investors not to place undue
reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information
currently available to the Company on the date hereof, and the
Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after
the date of this document, except as required by law.
Contacts:
Company Relations Contact:
Ryan Nadeau
Vice President,
Communications & Corporate Partnerships
(801) 432-9172
Investor Relations Contacts:
Cindy England
Director of Investor Relations
(801) 432-9036
investor@lifevantage.com
-or-
Scott Van Winkle
Managing Director, ICR
(617) 956-6736
scott.vanwinkle@icrinc.com
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024